Clinical Study Disclosures Will Make Drug Reviews More Efficient – Gottlieb

US FDA pilot program linking drug approval documents to sponsors' clinical study reports will improve review efficiency and access to information by medical researchers and drug developers, commissioner says; move also could aid sponsors when it comes to reimbursement decision-making, Foley and Lardner's Rosen predicts.

Carrot sticks

US FDA Commissioner Scott Gottlieb believes the potential for "review efficiencies" will entice manufacturers to allow public posting of their clinical study reports (CSRs) after a drug application's approval.

Whether this is enough of a carrot stick to persuade manufacturers to allow the release of their clinical trial data...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Product Reviews

More from Pink Sheet